Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
The stock recently closed at US$135.80, with a 6.1% gain over the last 7 days, a 14.6% decline over 30 days, a 2.6% return year to date, a 39.9% return over 1 year, a very large 3 year return that is around 11x, and a 64.9% decline over 5 years, which gives a mixed picture of recent and longer term sentiment. These varied returns have put GeneDx back on the radar for investors who are trying to interpret what the recent price strength and past volatility mean for the current opportunity. With no major recent company specific headlines provided here, the focus naturally shifts to whether the current share price lines up with reasonable estimates of value. On Simply Wall St's 6 point valuation check, GeneDx scores 3 out of 6, as shown in the valuation summary . Next we will look at what different valuation methods say about the stock today, before finishing with a way of assessing value that can give you a more complete picture. GeneDx Holdings delivered 39.9% returns over the la
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns [Yahoo! Finance]Yahoo! Finance
- 7MM Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease Market Opportunity Assessment and Forecasts 2024-2034 [Yahoo! Finance]Yahoo! Finance
- AI genome sequencing could transform rare disease diagnosis: GeneDx CEO [FOX Business Network]FOX Business Network
- GeneDx Announces GenomeDx Prenatalâ„¢, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care [Yahoo! Finance]Yahoo! Finance
- OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
OPK
Earnings
- 10/29/25 - Beat
OPK
Sec Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 4
- 11/19/25 - Form 4
- OPK's page on the SEC website